Search results for "Drug Interactions"
Rosuvastatin appears better than atorvastatin for mortality, cardio, liver outcomes in large database
Six-year all-cause mortality was lower among patients taking rosuvastatin than atorvastatin, but the difference was only about a percentage point, a study of patients in the United Kingdom and China found.
https://immattersacp.org/weekly/archives/2024/10/29/5.htm
29 Oct 2024
Use caution with colchicine's many drug interactions
A coauthor of “The Top 100 Drug Interactions” offers advice for improved management of colchicine.
https://immattersacp.org/archives/2023/09/use-caution-with-colchicines-many-drug-interactions.htm
1 Sep 2023
Recommendations on avoiding drug-drug interactions, data on recovery after ventilation
A panel of experts offered advice on avoiding drug-drug interactions when prescribing nirmatrelvir-ritonavir for patients with COVID-19, and two studies offered good news about postdischarge outcomes in COVID-19 patients who underwent a tracheostomy.
https://immattersacp.org/weekly/archives/2022/03/01/4.htm
1 Mar 2022
Considerations about cannabis
As more states legalize recreational and medical cannabis, hospital physicians are finding themselves caring for regular users more frequently.
https://immattersacp.org/archives/2024/05/considerations-about-cannabis.htm
1 May 2024
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://immattersacp.org/weekly/archives/2022/05/17/2.htm
17 May 2022
CAP presents challenges for clinicians
While not treating patients with pneumonia could be catastrophic, giving antibiotics to those who don't have it also causes harm.
https://immattersacp.org/archives/2024/06/cap-presents-challenges-for-clinicians.htm
1 Jun 2024
Guidance issued on drug-drug interactions for statins, heart meds
A new statement from the American Heart Association recommends that in patients taking amlodipine combined with simvastatin or lovastatin, the dosage of either statin should not exceed 20 mg/d, and for patients in whom statin-fibrate therapy is indicated, fenofibrate or fenofibric acid is preferred because of a lower rate of drug-drug interactions.
https://immattersacp.org/weekly/archives/2016/10/25/2.htm
25 Oct 2016
Making strides to stamp out HCV
While there's a goal of eliminating viral hepatitis globally by 2030, reports indicate a disproportionately high rate of infection and death in the United States among medically underserved populations.
https://immattersacp.org/archives/2024/05/making-strides-to-stamp-out-hcv.htm
1 May 2024
Apixaban appears safer than rivaroxaban, warfarin in cirrhosis with atrial fibrillation
Patients who initiated rivaroxaban or warfarin had significantly higher rates of major hemorrhagic events than those taking apixaban, a retrospective study of U.S. patients with cirrhosis and nonvalvular atrial fibrillation found.
https://immattersacp.org/weekly/archives/2024/07/09/1.htm
9 Jul 2024
Potential problematic prescribing in older women
Prescription of systemic estrogen therapy after menopause could be a red flag for use of other medications linked to dementia.
https://immattersacp.org/archives/2024/04/potential-problematic-prescribing-in-older-women.htm
1 Apr 2024